<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from the financial statements included in the Form 10-QSB of Endogen, Inc. to which this exhibit is a part and is qualified in its entirety by reference to such financial statements. </LEGEND> <CIK> 0000894020 <NAME> Endogen, Inc. <MULTIPLIER> 1,000 <CURRENCY> U.S. Dollars <PERIOD-TYPE> 3-mos <FISCAL-YEAR-END> May-31-1997 <PERIOD-START> Jun-01-1996 <PERIOD-END> Aug-31-1996 <EXCHANGE-RATE> 1 <CASH> 717 <SECURITIES> 0 <RECEIVABLES> 1,570 <ALLOWANCES> 20 <INVENTORY> 1,332 <CURRENT-ASSETS> 3,878 <PP&E> 2,538 <DEPRECIATION> 705 <TOTAL-ASSETS> 6,618 <CURRENT-LIABILITIES> 2,000 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 30 <OTHER-SE> 2,982 <TOTAL-LIABILITY-AND-EQUITY> 6,618 <SALES> 2,226 <TOTAL-REVENUES> 2,226 <CGS> 809 <TOTAL-COSTS> 2,032 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 78 <INCOME-PRETAX> 116 <INCOME-TAX> 0 <INCOME-CONTINUING> 116 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 116 <EPS-PRIMARY> .04 <EPS-DILUTED> .04